| abstract |
As used herein, comprising administering to a subject having atherosclerosis an effective amount of an isolated binding molecule that specifically binds to semaphorin-4D (SEMA4D) or its high affinity Plexin-B1 receptor , a method of reducing, inhibiting, inhibiting and/or delaying atherosclerotic plaque growth or angiogenesis in the subject is provided. |